IDH2 and acute myeloid leukemia: The worldwide frequencies of IDH1 and IDH2 mutations in newly diagnosed AML patients range from 2% to 14% and 1% to 19%, respectively, with the mutations mostly restricted to codon R132 of IDH1 and codon R140 of IDH2 [5,15,18-32].